What is the projected market valuation for the organ on-chip market in South America by 2035?

The projected market valuation for the organ on-chip market in South America is $49.1 Million by 2035. Read More

What was the overall market valuation for the organ on-chip market in South America in 2024?

The overall market valuation for the organ on-chip market in South America was $32.85 Million in 2024. Read More

What is the expected CAGR for the organ on-chip market in South America during the forecast period 2025 - 2035?

The expected CAGR for the organ on-chip market in South America during the forecast period 2025 - 2035 is 3.72%. Read More

Which organ-on-chip types are projected to have the highest valuations in South America?

The organ-on-chip types projected to have the highest valuations include Liver-on-Chip at $8.0 Million and Lung-on-Chip at $7.0 Million. Read More

What applications are driving growth in the organ on-chip market in South America?

The applications driving growth include Drug Discovery, projected to reach $18.5 Million, and Toxicology Research, expected to reach $22.0 Million. Read More

Who are the key players in the South America organ on-chip market?

Key players in the South America organ on-chip market include Emulate, TissUse, Mimetas, Organovo, and Synlogic. Read More

What is the valuation range for the Kidney-on-Chip segment in South America?

The valuation range for the Kidney-on-Chip segment in South America is between $4.0 Million and $5.5 Million. Read More

Which end-users are contributing to the organ on-chip market in South America?

End-users contributing to the organ on-chip market include Pharmaceutical Companies, with a valuation range of $12.85 Million to $18.5 Million. Read More

What is the valuation range for the Skin-on-Chip segment in South America?

The valuation range for the Skin-on-Chip segment in South America is between $3.0 Million and $4.0 Million. Read More

How does the organ on-chip market in South America compare to other regions?

While specific comparisons to other regions are not provided, the growth trajectory in South America appears promising with a projected valuation increase to $49.1 Million by 2035. Read More

South America Organ On Chip Market

South America Organ-On-Chip Market Research Report By Organ Type (Lung-on-Chip, Heart-on-Chip, Liver-on-Chip, Intestine-on-Chip, Kidney-on-Chip, Human-on-Chip), By Application (Drug Discovery, Toxicology Research, Others), By End-User (Pharmaceutical Companies, Research Organizations, Others) andBy Regional (Brazil, Mexico, Argentina, Rest of South America) - Growth & Industry Forecast 2025 To 2035

Forecast Period

2025 - 2035

CAGR

3.72%

2024 Market Size

$ 32.85 Million

2035 Market Size

$ 49.1 Million

Medical Device ● Updated August 2026 Report ID: MRFR/MED/49556-HCR | Pages: 200 | Author: Nidhi Mandole, Rahul Gotadki

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Pharmaceutical, BY Organ Type (USD Million)
  1. 4.1.1 Lung-on-Chip
  2. 4.1.2 Heart-on-Chip
  3. 4.1.3 Liver-on-Chip
  4. 4.1.4 Intestine-on-Chip
  5. 4.1.5 Kidney-on-Chip
  6. 4.1.6 Skin-on-Chip
  7. 4.1.7 Blood-Brain Barrier-on-Chip
  8. 4.1.8 Human-on-Chip
2. 4.2 Pharmaceutical, BY Application (USD Million)
  1. 4.2.1 Drug Discovery
  2. 4.2.2 Toxicology Research
  3. 4.2.3 Others
3. 4.3 Pharmaceutical, BY End-User (USD Million)
  1. 4.3.1 Pharmaceutical Companies
  2. 4.3.2 Research Organizations
  3. 4.3.3 Others
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Pharmaceutical
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Emulate (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 TissUse (DE)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Mimetas (NL)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Organovo (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Synlogic (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Hesperos (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 InSphero (CH)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Reinnervate (GB)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Tissot (FR)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 SOUTH AMERICA MARKET ANALYSIS BY ORGAN TYPE
3. 6.3 SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
4. 6.4 SOUTH AMERICA MARKET ANALYSIS BY END-USER
5. 6.5 KEY BUYING CRITERIA OF PHARMACEUTICAL
6. 6.6 RESEARCH PROCESS OF MRFR
7. 6.7 DRO ANALYSIS OF PHARMACEUTICAL
8. 6.8 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
9. 6.9 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
10. 6.10 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
11. 6.11 PHARMACEUTICAL, BY ORGAN TYPE, 2024 (% SHARE)
12. 6.12 PHARMACEUTICAL, BY ORGAN TYPE, 2024 TO 2035 (USD Million)
13. 6.13 PHARMACEUTICAL, BY APPLICATION, 2024 (% SHARE)
14. 6.14 PHARMACEUTICAL, BY APPLICATION, 2024 TO 2035 (USD Million)
15. 6.15 PHARMACEUTICAL, BY END-USER, 2024 (% SHARE)
16. 6.16 PHARMACEUTICAL, BY END-USER, 2024 TO 2035 (USD Million)
17. 6.17 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY ORGAN TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY APPLICATION, 2025-2035 (USD Million)
  3. 7.2.3 BY END-USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

South America South America Organ On Chip Market Segmentation

South America Organ On Chip Market By Organ Type (USD Million, 2025-2035)

Lung-on-Chip
Heart-on-Chip
Liver-on-Chip
Intestine-on-Chip
Kidney-on-Chip
Skin-on-Chip
Blood-Brain Barrier-on-Chip
Human-on-Chip

South America Organ On Chip Market By Application (USD Million, 2025-2035)

Drug Discovery
Toxicology Research
Others

South America Organ On Chip Market By End-User (USD Million, 2025-2035)

South America Organ On Chip Market Companies
Research Organizations
Others

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”